EP3275892
Forsamruna RSV F mótefnavakar
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
14.5.2012EP published:
8.1.2020EP application number:
17191721.4
EP translation filed:
16.3.2020Grant published:
15.4.2020EPO information:
European Patent Register
Max expiry date:
13.5.2032Expiry date:
13.5.2021
Title:
PRE-FUSION RSV F ANTIGENS
Timeline
Today
14.5.2012EP application
8.1.2020EP Publication
16.3.2020Translation submitted
15.4.2020Registration published
13.5.2021Expires
Owner
Name:
GlaxoSmithKline Biologicals S.A.Address:
Rue de l'Institut, 89, 1330 Rixensart, BE
Inventor
Name:
SWANSON, KurtAddress:
Emeryville, CA 94662-8097, US
Name:
CARFI, AndreaAddress:
Emeryville, CA 94662-8097, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161486005 PDate:
13.5.2011Country:
US
Classification
Categories:
C07K 14/135
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 14.4.2020
Expires: 13.5.2021
Payer: Örn Þór slf.